3Fareed Haas S, Sasaharan H. Past present and future consider ations on low molecular weight heparin differentiation:an Epihegne[J]. Seminarsin Thromb and Hemost , 1999,25(3) :145146.
4Ross R. Mechanisms of disease:. Atherosclerosis-an infammatory disease[J]. N Engl J Med , 1999,340:115.
4[3]Steffensen FH,Kristensen K,Ejlersen E,et al.Major hae-morrhagic complications during oral anticoagulant therapy in a Danish population-based cohort[J].J Intern Med,1997,242(6):497-503.
5Ollendorf DA, Vera Llonch M, Oster G. Cost of venous thrombosis following major orthopaedic surgery in hospitalized patients[J]. Am J Health Syst Pharm , 2002,59:1750-1754.
6Ennis RS. Postoperative deep vein thrombosis prophylaxis: a retrospective analysis in 1000 consecutive hop fracture patients treated in a community hospital setting[J]. J South Orthop Assoc , 2003, 12:10-17.
7Bates SM, Grand'Maison A, Johnston M, et al . A latex D-dimer reliably excludes venous thromboembolism [J]. Arch Intern Med , 2001,161:447-453.
